PV Bulletin

YJB response to the PAVA rollout extension

The YJB expresses strong opposition to PAVA use in youth custody despite its extended rollout at Young Offender Institutions.

Primary source: Open Government Licence v3.0

PV Impact Brief

Urgency: HighConfidence: high

What changed

The Youth Justice Board publicly stated its opposition to the extended use of PAVA in youth custody, characterizing this extension as a step in the wrong direction and advocating for reforms toward smaller, professional units for youth management.

Why it matters

This response could reshape compliance practices concerning the use of PAVA in youth institutions, influencing future regulations and treatment standards in youth justice.

Action needed

Monitor compliance practices regarding PAVA use in youth custody settings and assess alignment with the YJB's concerns and evidential claims on efficacy and safety.

Relevant for
Regulatory Intelligence Lead
Processes impacted
Signal Management
Owner

Regulatory Intelligence Lead

Review cadence

Review in the next regulatory intelligence cycle.

Evidence and confidence

Confidence: highSource updated: Sep 3, 2026

Full briefing

Practical implication

Monitor compliance practices regarding PAVA use in youth custody settings and assess alignment with the YJB's concerns and evidential claims on efficacy and safety.

The Youth Justice Board (YJB) has formally opposed the extension of the PAVA (synthetic pepper spray) rollout at Young Offender Institutions, highlighting concerns about its lack of efficacy in reducing violence and the potential for significant harm, particularly to vulnerable groups.

What changed: The Youth Justice Board publicly stated its opposition to the extended use of PAVA in youth custody, characterizing this extension as a step in the wrong direction and advocating for reforms toward smaller, professional units for youth management.

Why it matters: This response could reshape compliance practices concerning the use of PAVA in youth institutions, influencing future regulations and treatment standards in youth justice.

Practical implication: Monitor compliance practices regarding PAVA use in youth custody settings and assess alignment with the YJB's concerns and evidential claims on efficacy and safety.

View original source

  • Source: MHRA - News and communications
  • Published at source: 2026-09-03T00:00:00.000Z
  • Discovered by monitor: 2026-09-03T22:08:58.978Z

Published from the regulator source ingestion pipeline after PV impact triage.

Related updates for your role

publicFDA · USA · Updated Sep 4, 2026

FDA Grants Accelerated Approval to Etcamah for Advanced Breast Cancer

Urgency: High

Regulatory teams must prepare for updating labeling to include details on the new indication and required diagnostic methods, along with planning for the confirmatory studies mandated by the FDA.

Signal ManagementLabelingRegulatory Intelligence Lead
SOP Impact2 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward
publicMHRA · UK · Updated Sep 4, 2026

Change to the definition of regulated activity with children from 1 September 2026

Urgency: High

Organizations must re-evaluate roles related to children's activities and prepare to request Enhanced DBS checks including access to the Children’s Barred List check starting from 1 September 2026.

Country ComplianceRegulatory Intelligence Lead
SOP Impact1 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward
publicUK Health Security Agency · UK · Updated Sep 7, 2026

Low Flu Vaccination Rates Among Primary School Children

Urgency: High

Parents are reminded to complete and return flu vaccination consent forms promptly as vaccination sessions in schools are set to start this week, aiming for completion by late November.

Signal ManagementPV Quality Lead
SOP Impact1 SOPs
ConfidenceHigh
Relevant for: PV Quality Lead, Medical Safety Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward
publicANSM (France) · France · Updated Sep 7, 2026Translated From French

Recall of Gore Viabahn Endoprosthesis with Bioactive Heparin Coating

Urgency: High

Health establishments receiving affected devices must be notified, and protocols established to ensure compliance with the recall.

Signal ManagementQPPV
SOP Impact1 SOPs
ConfidenceHigh
Relevant for: QPPV, Medical Safety Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward